You are here: All Products  > Harbour BioMed Starts Phase III Trial of mAb for Myasthenia Gravis

Harbour BioMed Starts Phase III Trial of mAb for Myasthenia Gravis

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products